PT - JOURNAL ARTICLE AU - Ana Tereza do N S F Fernandes AU - Eujessika K. Rodrigues AU - Eder R. Araújo AU - Magno F. Formiga AU - Priscilla K. Sá Horan AU - Ana Beatriz N. S. Ferreira AU - Humberto A. Barbosa AU - Paulo S. Barbosa TI - Risk factors and survival in patients with COVID-19 in northeastern Brazil AID - 10.1101/2022.01.27.22269602 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.27.22269602 4099 - http://medrxiv.org/content/early/2022/01/27/2022.01.27.22269602.short 4100 - http://medrxiv.org/content/early/2022/01/27/2022.01.27.22269602.full AB - BACKGROUND Countries have focused research on developing strategies to fight COVID-19, prevent hospitalizations, and maintain economic activities.OBJECTIVE This study aimed to establish a survival analysis and identify risk factors for patients with COVID-19 in a upper middle-income city in Brazil.METHODS We performed a retrospective cohort study with 280 hospitalized patients with COVID-19. The eCOVID platform provided data used to monitor COVID-19 cases and help communication between professionals.RESULTS Survival analysis showed that age ≥ 65 years was associated with decreased survival (54.8%). Females had lower survival rate than males (p=0.01). Regarding risk factors, urea concentration (p<0.001), hospital LOS (p=0.002), oxygen concentration (p=0.005), and age (p=0.02) were associated with death.CONCLUSION Age, hospital LOS, high blood urea concentration, and low oxygen concentration were associated with death by COVID-19 in the studied population. These findings corroborate with studies conducted in research centers worldwide.Key Findings Some parameters assessed during hospital admission may identify patients with COVID-19 with high risk of progressing to severe conditions and early identification of risk factors and continuous monitoring of laboratory tests may prevent progression to severe disease.Key Implications Knowledge regarding main signs and symptoms of COVID-19 and associated risk factors helps the population manage and monitor the disease at home and identify early signs of severity. Also, more information about COVID-19, such as prevalence, specific characteristics in certain regions, and treatments, must become public to encourage the population to participate in the control and contingency of the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was financed by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) (Finance Code CAPES EPIDEMIAS 09/2020) and Fundacao de Apoio a Pesquisa do Estado da Paraiba Brasil (FAPESQ) (Finance Code COVID19 003/2020).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by Ethics Committee of the State University of Paraiba, Campina Grande, Brazil (approval number 4.241.971) and followed all ethical aspects involving research in humans and the Declaration of Helsinki and National Health Council (brazil's specific law 466/2012).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at doi 10.6084/m9.figshare.18858473 https://figshare.com/s/439d0d45b7b3e442728f